NCT01541592

Brief Summary

It has been shown that intravenous fatty acids given to normal volunteers in the form of heparin and lipid emulsions will cause insulin resistance in a matter of a few hours. It is not known if this same phenomenon can be demonstrated with oral fat. The investigators are specifically interested in whether or not there are differences in the induction of insulin resistance between the 3 main classes of fatty acids (saturated, monounsaturated and polyunsaturated). The investigators also plan to evaluate endothelial dysfunction and blood pressure; both of which frequently accompany insulin resistance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 21, 2012

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 1, 2012

Completed
Same day until next milestone

Study Start

First participant enrolled

March 1, 2012

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
Last Updated

November 26, 2014

Status Verified

November 1, 2014

Enrollment Period

1.9 years

First QC Date

February 21, 2012

Last Update Submit

November 24, 2014

Conditions

Keywords

Insulin resistanceEndothelial dysfunctionsaturated fatmonounsaturated fatpolyunsaturated fat

Outcome Measures

Primary Outcomes (1)

  • Change in Insulin Sensitivity from Baseline at Two Weeks

    Insulin sensitivity will be measured twice (once at baseline following a nasoduodenal infusion of saline for 6 hours; two weeks later following a nasoduodenal infusion of a vegetable oil high in one of 3 fatty acids for 6 hours) using a euglycemic, hyperinsulinemic clamp as described by R. DeFronzo. The actual measurement is expressed as a glucose infusion rate.

    Average of 2 weeks.

Secondary Outcomes (2)

  • Change in Endothelial Function from Baseline at Two Weeks

    Average of two weeks

  • Change in Systolic Blood Pressure at Two Weeks

    Average of two weeks

Study Arms (3)

Saturated fat

ACTIVE COMPARATOR

Palm oil (rich in the saturated fat palmitate)

Other: Dietary fat

Monounsaturated fat

ACTIVE COMPARATOR

Olive oil (rich in the monounsaturated fat oleate)

Other: Dietary fat

Polyunsaturated fat

ACTIVE COMPARATOR

Safflower oil (rich in the polyunsaturated fat linoleate)

Other: Dietary fat

Interventions

On the study day, each participant will receive 100 grams of a randomly assigned fat via a nasoduodenal tube. The oil will be infused at a rate of \~1 tablespoon per hour so that the total infusion time will be 6 hours.

Monounsaturated fatPolyunsaturated fatSaturated fat

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Lean,healthy adults 18 - 40
  • No chronic medications (birth control pills allowed)
  • Weight stable
  • Normal fasting labs performed at screening
  • Body mass index ≤ 25 kg/M\^2 .

You may not qualify if:

  • Insulin dependent diabetes
  • Thyroid disease
  • History of diabetes or heart disease
  • History of type 2 diabetes in parent or sibling

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Insulin Resistance

Interventions

Dietary Fats

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

FatsLipidsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Robert Nelson, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Family Medicine and Medicine

Study Record Dates

First Submitted

February 21, 2012

First Posted

March 1, 2012

Study Start

March 1, 2012

Primary Completion

February 1, 2014

Study Completion

February 1, 2014

Last Updated

November 26, 2014

Record last verified: 2014-11

Locations